Epidarex Capital Closes New £102 Million UK Venture Fund to Build Successful Life Science Companies
June 22, 2020
New UK fund cornerstoned by £50 million investment from the British Business Bank, through its Enterprise Capital Funds (ECF) programme Epidarex Capital III UK LP